Serum Levels of Growth Hormone-binding Protein and Insulin-like Growth Factor I in Children and Adolescents with Type 1 (insulin-dependent) Diabetes Mellitus

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1993 Mar 1

PMID 8462773

Citations 8

Authors

G Massa

L Dooms

R Bouillon

Affiliations

Soon will be listed here.

Abstract

Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulin-like growth factor I, serum levels of the high affinity growth hormone-binding protein, which is qualitatively and quantitatively related to the hepatic growth hormone receptor, and of insulin-like growth factor I were measured in 70 children and adolescents with Type 1 diabetes and 105 healthy control children. Analysis of variance revealed a significant negative effect of Type 1 diabetes on serum levels of the growth hormone-binding protein and of insulin-like growth factor I. In the diabetic patients, serum levels of the growth hormone-binding protein were positively related to body mass index and to insulin dose per kg body weight, and were not influenced by pubertal stage, gender, or plasma levels of haemoglobin A1c. Serum levels of insulin-like growth factor I increased during early puberty reaching peak levels at mid-puberty and decreasing thereafter. No relationship was found between serum levels of growth hormone-binding protein and of insulin-like growth factor I. Our data suggest that decreased liver somatogenic receptor levels, as reflected by the concentrations of circulating growth hormone-binding protein, play a minor role in the suppressed concentrations of circulating insulin-like growth factor I. Post-growth hormone receptor defects or changes in the insulin-like growth factor binding proteins probably contribute more to the lower serum levels of insulin-like growth factor I.

Citing Articles

Growth Hormone and Counterregulation in the Pathogenesis of Diabetes.

Dong X, Su L, Patti M Curr Diab Rep. 2022; 22(10):511-524.

PMID: 36001217 PMC: 9484610. DOI: 10.1007/s11892-022-01488-7.

Metabolically Active Brown Adipose Tissue Is Found in Adult Subjects with Type 1 Diabetes.

Eriksson O, Selvaraju R, Berglund M, Espes D Int J Mol Sci. 2019; 20(23).

PMID: 31757005 PMC: 6928828. DOI: 10.3390/ijms20235827.

Linear Growth in Children and Adolescents with Type 1 Diabetes Mellitus.

Santi E, Tascini G, Toni G, Berioli M, Esposito S Int J Environ Res Public Health. 2019; 16(19).

PMID: 31574933 PMC: 6801810. DOI: 10.3390/ijerph16193677.

FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice.

Ling A, Gearing M, Semova I, Shin D, Clements R, Lai Z Endocrinology. 2018; 159(3):1253-1263.

PMID: 29300910 PMC: 5802805. DOI: 10.1210/en.2017-00870.

Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.

Raisingani M, Preneet B, Kohn B, Yakar S Growth Horm IGF Res. 2017; 34:13-21.

PMID: 28482269 PMC: 5516798. DOI: 10.1016/j.ghir.2017.04.003.

References

Edge J, Dunger D, Matthews D, Gilbert J, Smith C . Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab. 1990; 71(5):1356-62. DOI: 10.1210/jcem-71-5-1356. View

Silbergeld A, Lazar L, Erster B, KERET R, Tepper R, Laron Z . Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clin Endocrinol (Oxf). 1989; 31(3):295-303. DOI: 10.1111/j.1365-2265.1989.tb01253.x. View

Bornfeldt K, Arnqvist H, Enberg B, Mathews L, Norstedt G . Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol. 1989; 122(3):651-6. DOI: 10.1677/joe.0.1220651. View

Horner J, Kemp S, Hintz R . Growth hormone and somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1981; 53(6):1148-53. DOI: 10.1210/jcem-53-6-1148. View

Menon R, Arslanian S, May B, Cutfield W, Sperling M . Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1992; 74(4):934-8. DOI: 10.1210/jcem.74.4.1548360. View

Massa G, de Zegher F . Serum growth hormone-binding proteins in the human fetus and infant. Pediatr Res. 1992; 32(1):69-72. DOI: 10.1203/00006450-199207000-00013. View

Batch J, BAXTER R, Werther G . Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab. 1991; 73(5):964-8. DOI: 10.1210/jcem-73-5-964. View

Ambler G, Breier B, Surus A, Blair H, McCutcheon S, Silbergeld A . The interrelationship between and the regulation of hepatic growth hormone receptors and circulating GH binding protein in the pig. Acta Endocrinol (Copenh). 1992; 126(2):155-61. DOI: 10.1530/acta.0.1260155. View

Daughaday W, Trivedi B, Andrews B . The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development. J Clin Endocrinol Metab. 1987; 65(5):1072-4. DOI: 10.1210/jcem-65-5-1072. View

10.

Ymer S, Herington A . Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol Cell Endocrinol. 1985; 41(2-3):153-61. DOI: 10.1016/0303-7207(85)90018-8. View

11.

Holl R, Snehotta R, Siegler B, Scherbaum W, Heinze E . Binding protein for human growth hormone: effects of age and weight. Horm Res. 1991; 35(5):190-7. DOI: 10.1159/000181901. View

12.

BAXTER R, Turtle J . Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun. 1978; 84(2):350-7. DOI: 10.1016/0006-291x(78)90177-8. View

13.

Rogers D, Sherman L, GABBAY K . Effect of puberty on insulinlike growth factor I and HbA1 in type I diabetes. Diabetes Care. 1991; 14(11):1031-5. DOI: 10.2337/diacare.14.11.1031. View

14.

Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim M . The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism. 1992; 41(1):106-12. DOI: 10.1016/0026-0495(92)90198-j. View

15.

Massa G, Bouillon R . Serum levels of growth hormone-binding protein and insulin-like growth factor-I during puberty. Clin Endocrinol (Oxf). 1992; 37(2):175-80. DOI: 10.1111/j.1365-2265.1992.tb02303.x. View

16.

Arner P, Sjoberg S, Gjotterberg M, Skottner A . Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy. Diabetologia. 1989; 32(10):753-8. DOI: 10.1007/BF00274537. View

17.

Leung D, Spencer S, Cachianes G, HAMMONDS R, Collins C, Henzel W . Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 1987; 330(6148):537-43. DOI: 10.1038/330537a0. View

18.

Massa G, Mulumba N, Ketelslegers J, Maes M . Initial characterization and sexual dimorphism of serum growth hormone-binding protein in adult rats. Endocrinology. 1990; 126(4):1976-80. DOI: 10.1210/endo-126-4-1976. View

19.

Maes M, Underwood L, Ketelslegers J . Low serum somatomedin-C in insulin-dependent diabetes: evidence for a postreceptor mechanism. Endocrinology. 1986; 118(1):377-82. DOI: 10.1210/endo-118-1-377. View

20.

Baumann G, Stolar M, Amburn K, Barsano C, DeVries B . A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab. 1986; 62(1):134-41. DOI: 10.1210/jcem-62-1-134. View